Nano TransMed 2022, 1(2–4): e9130011 https://doi.org/10.26599/NTM.2022.9130011

Highlight |

Open Access | Issue | Published: 08 December 2022

Current challenges and potential directions towards nanotechnology in medicine and transformation

Show Author's Information Hide Author's Information Qianqian Ni^{¹^,²^,³}(

), Xiaoyuan Chen^{¹^,²^,³^,⁴}(

)

Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119074, Singapore

Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore

Nanomedicine Translational Research Program, NUS Center for Nanomedicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore

Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research (A*STAR) 61 Biopolis Drive, Proteos, Singapore 138673, Singapore

Cite this article:

Ni Q, Chen X. Current challenges and potential directions towards nanotechnology in medicine and transformation. Nano TransMed, 2022, 1(2–4): e9130011. https://doi.org/10.26599/NTM.2022.9130011

Download citation

EndNote(RIS)

BibTeX

7093

Views

129

Downloads

Citations

Crossref

N/A

WoS

N/A

Scopus

N/A

CSCD

Full text About this article

Full text

Outline

About this article

Current challenges and potential directions towards nanotechnology in medicine and transformation

Show Author's information Hide Author's Information Qianqian Ni^{¹^,²^,³}(

), Xiaoyuan Chen^{¹^,²^,³^,⁴}(

)

Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119074, Singapore

Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore

Nanomedicine Translational Research Program, NUS Center for Nanomedicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore

Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research (A*STAR) 61 Biopolis Drive, Proteos, Singapore 138673, Singapore

References(12)

[1]

Chen, H. M.; Zhang, W. Z.; Zhu, G. Z.; Xie, J.; Chen, X. Y. Rethinking Cancer Nanotheranostics. Nat. Rev. Mater. 2017, 2, 7024.

DOI Google Scholar

[2]

Auría-Soro, C.; Nesma, T.; Juanes-Velasco, P.; Landeira-Viñuela, A.; Fidalgo-Gomez, H.; Acebes-Fernandez, V.; Gongora, R.; Almendral Parra, M. J.; Manzano-Roman, R.; Fuentes, M. Interactions of Nanoparticles and Biosystems: Microenvironment of Nanoparticles and Biomolecules in Nanomedicine. Nanomaterials 2019, 9, 1365.

DOI Google Scholar

[3]

Fries, C. N.; Curvino, E. J.; Chen, J. L.; Permar, S. R.; Fouda, G. G.; Collier, J. H. Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health. Nat. Nanotechnol. 2021, 16, 1–14.

DOI Google Scholar

[4]

Irvine, D. J.; Dane, E. L. Enhancing cancer immunotherapy with nanomedicine. Nat. Rev. Immunol. 2020, 20, 321–334.

DOI Google Scholar

[5]

Chen, W.; Schilperoort, M.; Cao, Y. H.; Shi, J. J.; Tabas, I.; Tao, W. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis. Nat. Rev. Cardiol. 2022, 19, 228–249.

DOI Google Scholar

[6]

Musunuru, K.; Chadwick, A. C.; Mizoguchi, T.; Garcia, S. P.; DeNizio, J. E.; Reiss, C. W.; Wang, K.; Iyer, S.; Dutta, C.; Clendaniel, V. et al. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature 2021, 593, 429–434.

DOI Google Scholar

[7]

Barbier, A. J.; Jiang, A. Y.; Zhang, P.; Wooster, R.; Anderson, D. G. The clinical progress of MRNA vaccines and immunotherapies. Nat. Biotechnol. 2022, 40, 840–854.

DOI Google Scholar

[8]

Bhatia, S. N.; Chen, X. Y.; Dobrovolskaia, M. A.; Lammers, T. Cancer nanomedicine. Nat. Rev. Cancer 2022, 22, 550–556.

DOI Google Scholar

[9]

Boehnke, N.; Straehla, J. P.; Safford, H. C.; Kocak, M.; Rees, M. G.; Ronan, M.; Rosenberg, D.; Adelmann, C. H.; Chivukula, R. R.; Nabar, N. et al. Massively parallel pooled screening reveals genomic determinants of nanoparticle delivery. Science 2022, 377, eabm5551.

DOI Google Scholar

[10]

Dobrowolski, C.; Paunovska, K.; Schrader Echeverri, E.; Loughrey, D.; Da Silva Sanchez, A. J.; Ni, H. Z.; Hatit, M. Z. C.; Lokugamage, M. P.; Kuzminich, Y.; Peck, H. E. et al. Nanoparticle single-cell multiomic readouts reveal that cell heterogeneity influences lipid nanoparticle-mediated messenger RNA delivery. Nat. Nanotechnol. 2022, 17, 871–879.

DOI Google Scholar

[11]

Sago, C. D.; Lokugamage, M. P.; Paunovska, K.; Vanover, D. A.; Monaco, C. M.; Shah, N. N.; Gamboa Castro, M.; Anderson, S. E.; Rudoltz, T. G.; Lando, G. N. et al. High-throughput in vivo screen of functional MRNA delivery identifies nanoparticles for endothelial cell gene editing. Proc. Natl. Acad. Sci. USA 2018, 115, E9944–E9952.

DOI Google Scholar

[12]

Horejs, C. Organ chips, organoids and the animal testing conundrum. Nat. Rev. Mater. 2021, 6, 372–373.

DOI Google Scholar

About this article

Publication history

Rights and permissions

Publication history

Received: 20 November 2022

Accepted: 21 November 2022

Published: 08 December 2022

Issue date: December 2022

Copyright

Rights and permissions

The articles published in this open access journal are distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.